Enanta Pharmaceuticals
ENTA
#8679
Rank
ยฃ0.18 B
Marketcap
ยฃ6.33
Share price
-4.02%
Change (1 day)
-34.99%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -ยฃ37.62 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ65.25 Million. In 2025 the company made an earning of -ยฃ48.58 Million, an increase over its 2024 earnings that were of -ยฃ73.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ37.62 Million-22.55%
2025 -ยฃ48.58 Million-34.07%
2024 -ยฃ73.68 Million-23.87%
2023 -ยฃ96.77 Million4.39%
2022 -ยฃ92.71 Million-4.4%
2021 -ยฃ96.98 Million91.12%
2020 -ยฃ50.74 Million-407.13%
2019 ยฃ16.52 M-78.63%
2018 ยฃ77.31 M117.97%
2017 ยฃ35.47 M-574.65%
2016 -ยฃ7.48 Million-110.83%
2015 ยฃ69.02 M-4.5%
2014 ยฃ72.27 M-638.53%
2013 -ยฃ13.43 Million-137.98%
2012 ยฃ35.33 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.21 B-37,381.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ9.60 B-25,277.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ9.73 B-25,618.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ3.46 B-9,183.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.10 B-13,488.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.60 B-22,666.96%๐Ÿ‡บ๐Ÿ‡ธ USA